Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression

Cancer Letters

Volumn 334, Issue 1, 2013, Pages 101-108

  Hahm, Eun Ryeong ^a   Singh, Shivendra V ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Breast cancer; Survivin; Withaferin A; XIAP

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; SURVIVIN; WITHAFERIN A; X LINKED INHIBITOR OF APOPTOSIS; ANTINEOPLASTIC AGENT; BIRC3 PROTEIN, HUMAN; BIRC5 PROTEIN, HUMAN; WITHANOLIDE; XIAP PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT; ANIMAL; BREAST NEOPLASMS; DRUG EFFECTS; DRUG SCREENING; GENETICS; MCF 7 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

WITHANIA SOMNIFERA;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MCF-7 CELLS; MICE, NUDE; WITHANOLIDES; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84888197797     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.08.026     Document Type: Article

References (42)

1. Garodia P., Ichikawa H., Malani N., Sethi G., Aggarwal B.B. From ancient medicine to modern medicine: Ayurvedic concepts of health and their role in inflammation and cancer. J. Soc. Integr. Oncol. 2007, 5(1):25-37.
2. Baliga M.S. Triphala, Ayurvedic formulation for treating and preventing cancer: a review. J. Altern. Complement. Med. 2010, 16(12):1301-1308.
3. Mishra L.C., Singh B.B., Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern. Med. Rev. 2000, 5(4):334-346.
4. Winters M. Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern. Med. Rev. 2006, 11(4):269-277.
5. Gupta S.K., Mohanty I., Talwar K.K., Dinda A., Joshi S., Bansal P., Saxena A., Arya D.S. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol. Cell. Biochem. 2004, 260(1-2):39-47.
6. Ahmad M., Saleem S., Ahmad A.S., Ansari M.A., Yousuf S., Hoda M.N., Islam F. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum. Exp. Toxicol. 2005, 24(3):137-147.
7. Panda S., Kar A. Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male mice. J. Pharm. Pharmacol. 1998, 50(9):1065-1068.
8. Devi P.U., Sharada A.C., Solomon F.E. Antitumor and radiosensitizing effects of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma-180. Indian J. Exp. Biol. 1993, 31(7):607-611.
9. Leyon P.V., Kuttan G. Effect of Withania somnifera on B16F-10 melanoma induced metastasis in mice. Phytother. Res. 2004, 18(2):118-122.
10. Padmavathi B., Rath P.C., Rao A.R., Singh R.P. Roots of Withania somnifera inhibit forestomach and skin carcinogenesis in mice. Evid. Based Complement. Alternat. Med. 2005, 2(1):99-105.
11. Widodo N., Kaur K., Shrestha B.G., Takagi Y., Ishii T., Wadhwa R., Kaul S.C. Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin. Cancer Res. 2007, 13(7):2298-2306.
12. Mathur R., Gupta S.K., Singh N., Mathur S., Kochupillai V., Velpandian T. Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis. J. Ethnopharmacol. 2006, 105(3):336-341.
13. Shohat B., Joshua H. Effect of withaferin A on ehrlich ascites tumor cells. II. Target tumor cell destruction in vivo by immune activation. Int. J. Cancer 1971, 8(3):487-496.
14. Devi P.U., Kamath R., Rao B.S. Radiosensitization of a mouse melanoma by withaferin A: in vivo studies. Indian J. Exp. Biol. 2000, 38(5):432-437.
15. Manoharan S., Panjamurthy K., Menon V.P., Balakrishnan S., Alias L.M. Protective effect of Withaferin-A on tumour formation in 7,12-dimethylbenz[a]anthracene induced oral carcinogenesis in hamsters. Indian J. Exp. Biol. 2009, 47(1):16-23.
16. Srinivasan S., Ranga R.S., Burikhanov R., Han S.S., Chendil D. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res. 2007, 67(1):246-253.
17. Stan S.D., Hahm E.R., Warin R., Singh S.V. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res. 2008, 68(18):7661-7669.
18. Thaiparambil J.T., Bender L., Ganesh T., Kline E., Patel P., Liu Y., Tighiouart M., Vertino P.M., Harvey R.D., Garcia A., Marcus A.I. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int. J. Cancer 2011, 129(11):2744-2755.
19. Stan S.D., Zeng Y., Singh S.V. Ayurvedic medicine constituent withaferin A causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr. Cancer 2008, 60(S1):51-60.
20. Oh J.H., Lee T.J., Kim S.H., Choi Y.H., Lee S.H., Lee J.M., Kim Y.H., Park J.W., Kwon T.K. Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation. Apoptosis 2008, 13(12):1494-1504.
21. Mandal C., Dutta A., Mallick A., Chandra S., Misra L., Sangwan R.S., Mandal C. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis 2008, 13(12):1450-1464.
22. E.R. Hahm, S.V. Singh, Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells. Curr. Cancer Drug Targets, in press.
23. Hahm E.R., Moura M.B., Kelley E.E., Van Houten B., Shiva S., Singh S.V. Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One 2011, 6(8):e23354.
24. Mayola E., Gallerne C., Esposti D.D., Martel C., Pervaiz S., Larue L., Debuire B., Lemoine A., Brenner C., Lemaire C. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis 2011, 16(10):1014-1027.
25. Yang E.S., Choi M.J., Kim J.H., Choi K.S., Kwon T.K. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. Chem. Biol. Interact. 2011, 190(1):9-15.
26. Hahm E.R., Lee J., Huang Y., Singh S.V. Withaferin A suppresses estrogen receptor-α expression in human breast cancer cells. Mol. Carcinog. 2011, 50(8):614-624.
27. Ichikawa H., Takada Y., Shishodia S., Jayaprakasam B., Nair M.G., Aggarwal B.B. Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-κB (NF-κB) activation and NF-κB-regulated gene expression. Mol. Cancer Ther. 2006, 5(6):1434-1445.
28. Lee J., Hahm E.R., Singh S.V. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis 2010, 31(11):1991-1998.
29. Yang H., Shi G., Dou Q.P. The tumor proteasome is a primary target for the natural anticancer compound withaferin A isolated from "Indian winter cherry" Mol. Pharmacol. 2007, 71(2):426-437.
30. Mohan R., Hammers H.J., Bargagna-Mohan P., Zhan X.H., Herbstritt C.J., Ruiz A., Zhang L., Hanson A.D., Conner B.P., Rougas J., Pribluda V.S. Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 2004, 7(2):115-122.
31. LaCasse E.C., Baird S., Korneluk R.G., MacKenzie A.E. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998, 17(25):3247-3259.
32. Deveraux Q.L., Reed J.C. IAP family proteins - suppressors of apoptosis. Genes Dev. 1999, 13(3):239-252.
33. 2/M arrest and inducing apoptosis. Carcinogenesis 2003, 24(5):891-897.
34. Powolny A.A., Bommareddy A., Hahm E.R., Normolle D.P., Beumer J.H., Nelson J.B., Singh S.V. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J. Natl Cancer Inst. 2011, 103(7):571-584.
35. Galbán S., Duckett C.S. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2010, 17(1):54-60.
36. Srinivasula S.M., Ashwell J.D. IAPs: what's in a name?. Mol. Cell 2008, 30(2):123-135.
37. Dubrez-Daloz L., Dupoux A., Cartier J. IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 2008, 7(8):1036-1046.
38. Dean E.J., Ranson M., Blackhall F., Dive C. X-linked inhibitor of apoptosis protein as a therapeutic target. Expert Opin. Ther. Targets 2007, 11(11):1459-1471.
39. Yang Y., Fang S., Jensen J.P., Weissman A.M., Ashwell J.D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 2000, 288(5467):874-877.
40. Altieri D.C. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr. Opin. Cell Biol. 2006, 18(6):609-615.
41. Ambrosini G., Adida C., Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 1997, 3(8):917-921.
42. Pennati M., Folini M., Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 2007, 28(6):1133-1139.